10X Wins Patent Case Against Bio-Rad at Trade Agency

Feb. 12, 2020, 10:12 PM

Bio-Rad infringes three 10X Genomics patents related to genetic-sequencing technology, U.S. International Trade Commission said in a notice on its website.

  • Commission granted 10X request to block Bio-Rad chips and cartridges that partition genetic material in droplets so their DNA can be analyzed and sequenced; technology is used in basic scientific and medical research
    • Complaint targets Bio-Rad’s ddSEQ products used to create a type of barcode on the cells so they can be sequenced
  • Import ban is subject to review by Trump administration, which can veto the order on public policy grounds
  • 10X had filed the complaint in retaliation after ...

To read the full article log in. To learn more about a subscription click here.